Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ATEC logo ATEC
Upturn stock ratingUpturn stock rating
ATEC logo

Alphatec Holdings Inc (ATEC)

Upturn stock ratingUpturn stock rating
$14.7
Last Close (24-hour delay)
Profit since last BUY-4.17%
upturn advisory
SELL
SELL since 1 day
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/17/2025: ATEC (1-star) is a SELL. SELL since 1 days. Simulated Profits (-4.17%). Updated daily EoD!

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

10 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $18.95

1 Year Target Price $18.95

Analysts Price Target For last 52 week
$18.95 Target price
52w Low $4.88
Current$14.7
52w High $16.7

Analysis of Past Performance

Type Stock
Historic Profit 3.61%
Avg. Invested days 34
Today’s Advisory SELL
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/17/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.18B USD
Price to earnings Ratio -
1Y Target Price 18.95
Price to earnings Ratio -
1Y Target Price 18.95
Volume (30-day avg) 10
Beta 1.03
52 Weeks Range 4.88 - 16.70
Updated Date 09/17/2025
52 Weeks Range 4.88 - 16.70
Updated Date 09/17/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.13

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -24.33%
Operating Margin (TTM) -6.19%

Management Effectiveness

Return on Assets (TTM) -7.61%
Return on Equity (TTM) -376.89%

Valuation

Trailing PE -
Forward PE 33.44
Enterprise Value 2653762138
Price to Sales(TTM) 3.19
Enterprise Value 2653762138
Price to Sales(TTM) 3.19
Enterprise Value to Revenue 3.89
Enterprise Value to EBITDA -18.89
Shares Outstanding 147983775
Shares Floating 116377400
Shares Outstanding 147983775
Shares Floating 116377400
Percent Insiders 20.78
Percent Institutions 69.11

ai summary icon Upturn AI SWOT

Alphatec Holdings Inc

stock logo

Company Overview

overview logo History and Background

Alphatec Holdings Inc. (ATEC) was founded in 2006. The company focuses on developing, manufacturing, and marketing spinal implant products and surgical instruments. It has grown through acquisitions and organic product development.

business area logo Core Business Areas

  • Spinal Implants: ATEC designs, develops, and markets a comprehensive line of spinal implant products used in spinal fusion surgery for the treatment of spinal disorders.
  • Surgical Instruments: ATEC provides a variety of surgical instruments for use during spinal surgery.
  • Biologics: ATEC offers biologic solutions to promote spinal fusion.
  • Navigation and Robotics: ATEC offers surgical navigation and robotics technologies to enhance surgical precision and efficiency.

leadership logo Leadership and Structure

ATEC is led by Patrick Miles, Chairman and CEO. The organizational structure consists of various departments including R&D, marketing, sales, and operations.

Top Products and Market Share

overview logo Key Offerings

  • Safe-Lock Plating System: A comprehensive plating system used in anterior cervical discectomy and fusion (ACDF) procedures. Market share information for specific plating systems is not readily available, but ATEC competes with Medtronic, Stryker, and Johnson & Johnson in the broader cervical plating market.
  • Invictus Spinal Fixation System: A pedicle screw system designed for posterior spinal fixation. Market share data is not publicly available. Competitors include Medtronic, Nuvasive, and Globus Medical.
  • EOS Imaging System: EOS imaging technology offers weight-bearing, low-dose full-body images for musculoskeletal conditions. Market share data is not readily available but competitors include Siemens Healthineers and GE Healthcare in imaging solutions.
  • ALPHA Navigation System: ALPHA Navigation System offers precise surgical navigation capabilities, enhancing accuracy and efficiency during spine procedures. Key competitors include Medtronic's StealthStation and Globus Medical's ExcelsiusGPS, but specific market share data for navigation systems is not publicly available.

Market Dynamics

industry overview logo Industry Overview

The spinal implant market is driven by an aging population, increasing prevalence of spinal disorders, and technological advancements in surgical techniques. The industry is highly competitive and subject to regulatory scrutiny.

Positioning

ATEC is a mid-sized player in the spinal implant market, focusing on innovation and strategic acquisitions to gain market share. Its competitive advantage lies in its comprehensive product portfolio and focus on advanced technologies.

Total Addressable Market (TAM)

The global spine market is estimated to be approximately $10 billion. ATEC aims to increase its market share through product innovation and strategic partnerships, positioning itself to capture a larger portion of the TAM.

Upturn SWOT Analysis

Strengths

  • Comprehensive Product Portfolio
  • Focus on Technological Innovation
  • Strategic Acquisitions
  • Strong Surgeon Relationships

Weaknesses

  • Smaller Market Share Compared to Larger Competitors
  • Dependence on Key Products
  • History of net losses

Opportunities

  • Expanding Product Portfolio Through R&D
  • Geographic Expansion into Emerging Markets
  • Increased Adoption of Minimally Invasive Surgery (MIS)
  • Strategic Partnerships and Collaborations

Threats

  • Intense Competition
  • Pricing Pressure
  • Regulatory Changes
  • Product Liability Litigation

Competitors and Market Share

competitor logo Key Competitors

  • Medtronic (MDT)
  • Stryker (SYK)
  • Johnson & Johnson (JNJ)
  • Globus Medical (GMED)
  • Nuvasive (NUVA)

Competitive Landscape

ATEC is a smaller player compared to the larger competitors like Medtronic and Stryker. ATEC focuses on innovation and strategic acquisitions to differentiate itself. Its advantage is its comprehensive portfolio and surgeon relationships; its disadvantage is its smaller scale.

Major Acquisitions

EOS imaging

  • Year: 2018
  • Acquisition Price (USD millions): 96.4
  • Strategic Rationale: Acquisition of EOS imaging provides ATEC with advanced imaging technology to enhance surgical planning and outcomes.

Growth Trajectory and Initiatives

Historical Growth: ATEC has experienced significant revenue growth over the past several years, driven by product innovation and strategic acquisitions.

Future Projections: Analyst estimates project continued revenue growth, but profitability remains a challenge. Future growth depends on successful product launches and effective cost management.

Recent Initiatives: Recent initiatives include launching new spinal implant products, expanding the sales force, and investing in robotic and navigation technologies.

Summary

Alphatec Holdings shows promise with revenue growth driven by innovation and acquisitions. While they are a smaller player compared to competitors, strategic efforts focus on technological advancement to improve competitive positioning. Profitability remains a challenge; effective cost management and continued innovation are critical. The company must navigate competitive pressures and regulatory changes.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company SEC Filings (10-K, 10-Q)
  • Investor Presentations
  • Press Releases
  • Analyst Reports
  • Market Research Reports

Disclaimers:

The data and analysis provided are based on publicly available information and analyst estimates, and are subject to change. This is not financial advice. Consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Alphatec Holdings Inc

Exchange NASDAQ
Headquaters Carlsbad, CA, United States
IPO Launch date 2006-06-02
Executive Chairman, CEO & President Mr. Patrick S. Miles
Sector Healthcare
Industry Medical Devices
Full time employees 867
Full time employees 867

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.